ctDNA Based MRD Testing for NAC Monitoring in TNBC

ctDNA Based MRD Testing for NAC Monitoring in TNBC
Conditions: TNBC – Triple-Negative Breast Cancer; Minimal Residual Disease

Sponsors: Personalis Inc.

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 31, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments